Related Experiment Video
Updated: Jun 6, 2025
07:49
Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
Published on: March 17, 2023
2.3K
Cancer Therapies Targeting Cellular Metabolism
Benjamin Morris1, Alejandro Gutierrez2
1Biomedical and Biological Sciences Program, Harvard Medical School, Boston, Massachusetts 02115, USA.
Cold Spring Harbor Perspectives in Medicine
|November 25, 2024
Summary
Cancer cells rewire metabolism for growth, creating vulnerabilities exploitable in cancer therapy. Targeting these metabolic dependencies and immune interactions offers promising therapeutic strategies.
Area of Science:
- Oncology
- Cancer Biology
- Metabolic Pathways
Background:
- Cancer arises from mutations causing uncontrolled cell growth and invasion.
- Tumor cells adapt metabolism to survive nutrient-poor environments.
- Metabolic alterations in cancer create dependencies that can be therapeutically targeted.
Purpose of the Study:
- To explore the therapeutic potential of targeting cancer metabolism.
- To discuss challenges in developing metabolic cancer therapies.
- To highlight how tumors exploit metabolic regulation of immunity.
Main Methods:
- Review of current literature on cancer metabolism and therapy.
- Analysis of specific examples of metabolic vulnerabilities in cancer.
- Discussion of immune evasion strategies involving metabolic regulation.
Main Results:
- Altered cellular metabolism is a hallmark of cancer, essential for tumor growth and survival.
- Specific metabolic pathways and enzymes can be mutated, creating unique tumor-promoting metabolites.
- Tumors manipulate cellular immunity through metabolic regulation, impacting therapeutic responses.
Conclusions:
- Targeting cancer metabolism presents a promising therapeutic avenue.
- Exploiting tumor-specific metabolic dependencies offers ideal therapeutic targets.
- Understanding metabolic regulation of anti-tumor immunity is crucial for effective cancer treatment.
Related Concept Videos
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:53Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:46Electron Transport Chain: Complex I and II
11.7K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
11.7K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
02:34Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K